SCHEMBL4222869

SCHEMBL4222869

Cc1ccc(Nc2cc(CCc3ccccc3)ccc2C(=O)O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.60
MEN1 O00255 1/20 0.60
RECQL P46063 1/20 0.60
BLM P54132 1/20 0.60
KMT2A Q03164 1/20 0.60
AKR1C3 P42330 7/20 0.58
AKR1C2 P52895 7/20 0.58
SIRT2 Q8IXJ6 1/20 0.53
ALDH1A1 P00352 2/20 0.46
MAPT P10636 1/20 0.46
GFER P55789 1/20 0.46
NGLY1 Q96IV0 1/20 0.46
CTSV O60911 2/20 0.45
CTSL P07711 2/20 0.45
PLK1 P53350 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4223020 0.90 MEN1 (0.63) TDP1MEN1RECQLBLMKMT2A
SCHEMBL4218669 0.90 AKR1C3 (0.55) TDP1MEN1RECQLBLMKMT2A
SCHEMBL4216718 0.89 KMT2A (0.60) TDP1MEN1RECQLBLMKMT2A
SCHEMBL4219141 0.88 MEN1 (0.61) TDP1MEN1RECQLBLMKMT2A
SCHEMBL4219998 0.88 MEN1 (0.61) TDP1MEN1RECQLBLMKMT2A
SCHEMBL4220303 0.87 KMT2A (0.57) TDP1MEN1RECQLBLMKMT2A
SCHEMBL4213235 0.87 AKR1C3 (0.60) TDP1MEN1RECQLBLMKMT2A
SCHEMBL4225606 0.87 MEN1 (0.54) TDP1MEN1RECQLBLMKMT2A
SCHEMBL4210607 0.87 AKR1C3 (0.62) TDP1MEN1RECQLBLMKMT2A
SCHEMBL4215807 0.86 MEN1 (0.67) TDP1MEN1RECQLBLMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 US disclosed
EP-1860098-B1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO LTD (JP) 2012-11-14 EP disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 US disclosed
EP-1860098-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-11-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP11, MMP3 TDP1 4378/4885MEN1 2810/4885RECQL 4129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.